Utkarsh Ojha

379 posts

Utkarsh Ojha

Utkarsh Ojha

@CardioKarsh

Cardiology & Internal Medicine Registrar | Editorial Board @BMC_series #BMCCardiovascDisord | Prior: Health Policy @WHO Investment Banking @Jefferies

United Kingdom Katılım Ocak 2013
530 Takip Edilen242 Takipçiler
Sabitlenmiş Tweet
Utkarsh Ojha
Utkarsh Ojha@CardioKarsh·
Safety, Efficacy, and Effectiveness of Coronary Sinus Reducer Implantation in Refractory Angina: A Meta-Analysis | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.…
English
1
0
4
255
Utkarsh Ojha retweetledi
C. Michael Gibson MD
C. Michael Gibson MD@CMichaelGibson·
Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the MOMENTUM study: Among U.S. patients with resistant HTN, 27.3% were found to have endogenous hypercortisolism, a significantly higher prevalence than previously recognized. #ACC26 Watch video here: clinicaltrialresults.org/dr-deepak-bhat…
English
1
24
65
9.9K
Utkarsh Ojha retweetledi
George Tolis
George Tolis@georgetolisjr·
Cardiac surgical societies should require all “experts” to turn in a case list before they can sit on a national meeting panel and lecture the audience about “how I do it” or “how I teach it”.
English
23
26
300
73K
Utkarsh Ojha retweetledi
Hatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA
Following many requests from colleagues worldwide for access to my recorded webinars, I’ve reactivated my dormant YouTube channel where you’ll find a dedicated playlist with 20+ full-length lectures from previous open-access sessions — all freely available — and I’ll continue adding more. Explore here: @EchoSoliman" target="_blank" rel="nofollow noopener">youtube.com/@EchoSoliman Hoping these resources continue to support global learning and collaboration in critical care echocardiography & POCUS. #EchoFirst #POCUS #EACVI
Hatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA tweet media
English
3
9
25
1.4K
Utkarsh Ojha retweetledi
John Mandrola, MD
John Mandrola, MD@drjohnm·
Under appreciated by many: in some hospital systems, the procedural cardiologists are the most conservative. Most aggressive can be the referral docs.
English
19
14
195
19.1K
Utkarsh Ojha retweetledi
CardiovascularCorner
CardiovascularCorner@TrackYourHeart·
This video witnesses the chaotic rhythm of ventricular fibrillation, a precursor to sudden cardiac arrest. Treatment : immediate defibrillation and cpr Source: @medi_cosity
English
1
26
143
7.4K
Utkarsh Ojha retweetledi
John Mandrola, MD
John Mandrola, MD@drjohnm·
The main reason to read this paper is as an example of observational study run amok “Among 253 pts at a single center…” With all due respect, please, resist the urge to do (and publish) such folly. Look at the early curve separation jacc.org/doi/10.1016/j.…
Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦@DrMarthaGulati

Retrospective analysis of patients with #HFrEF with ICD, #GLP1RA use was associated with significant ⤴️in heart rate & ⤴️ number of nonsustained ventricular events and total shock/antitachycardia pacing therapies @JACCJournals

English
9
12
65
39.3K
Utkarsh Ojha retweetledi
Hatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA
🚀 #ESCCongress 2025 was a great success! Honoured to serve as Faculty & Chair in sessions on HF, cardiogenic shock & novel #echofirst techniques. 📊 As #EACVI Secretary, we had a very fruitful board meeting where discussed the upcoming Vienna Congress (11–13 Dec) — EuroEcho, EuroCMR & ICNIC-CT under one roof! Our programme committee worked tirelessly to deliver cutting edge programme with lots of tutorials and workshops! 🤝 It was also wonderful to reconnect with friends and colleagues from around 🌍. With 33k+ attendees, A great success for the world's leading cardiology meeting ❤️.
Hatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA tweet mediaHatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA tweet mediaHatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA tweet mediaHatem Soliman Aboumarie, FRCP, FEACVI, FASE, FHEA tweet media
English
3
6
49
2.4K
Utkarsh Ojha retweetledi
American College of Cardiology
American College of Cardiology@ACCinTouch·
Coronary sinus reducer implantation may be safe & feasible, w/ promising antianginal efficacy in patients w/ refractory angina, according to a meta-analysis published in #JACCINT. However, larger trials are needed to assess efficacy. Read more: bit.ly/4oCoVt4
American College of Cardiology tweet media
English
2
18
60
8.3K
Utkarsh Ojha retweetledi
TCTMD
TCTMD@TCTMD·
Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis dlvr.it/TMT21f
TCTMD tweet media
English
0
4
11
1.3K